A case of primary liposarcoma of orbit and clinicopathological analysis

doi:10.3760/cma.j.issn.1007-1245.2024.10.028

International Medicine and Health Guidance News ›› 2024, Vol. 30 ›› Issue (10): 1720-1725.DOI: 10.3760/cma.j.issn.1007-1245.2024.10.028

• Case Report • Previous Articles Next Articles

A case of primary liposarcoma of orbit and clinicopathological analysis

Liu Susu, Wang Nana, Chang Wenli, Si Hang, Shi Wenya, Zhang Qian

Pathology Department, Binzhou Medical University Hospital, Binzhou 256603, China

Received:2024-01-09 Online:2024-05-15 Published:2024-06-03
Contact: Zhang Qian, Email: zhangqianbl@163.com
Supported by:
Natural Science Foundation of Shandong Province (ZR2015HL085); Shandong Province Medical Health Science and Technology Development Project (202201040792)

眼眶原发性脂肪肉瘤1例及临床病理分析

刘素素王娜娜常文丽司航石文雅张骞

滨州医学院附属医院病理科，滨州　256603

通讯作者: 张骞，Email：zhangqianbl@163.com
基金资助:
山东省自然科学基金（ZR2015HL085）；山东省医药卫生科技发展项目（202201040792）

Abstract

Abstract:

The paper reported a case of primary well-differentiated liposarcoma of orbit in Binzhou Medical University Hospital. The patient was a 52-year-old man with a 4-year history of mass growth in the left eye. Ocular examination revealed a sense of no light, orbital protrusion, inability to close the eyelids, displacement of the eyeball fixed above the temporal, and obvious conjunctival hyperemia and edema in the left eye. Imaging showed a large ellipselike mixed density shadow in the left orbit with clear boundary. Thus, an orbital tumorectomy was performed, and the diagnosis of well-differentiated liposarcoma was confirmed by histopathological examination.

Key words:

Orbit, Well-differentiated, Liposarcoma, Histopathology

摘要：

本文报道滨州医学院附属医院1例眼眶原发性高分化脂肪肉瘤（WDLS）患者。患者为52岁男性，因“发现左眼肿物生长4年”入院。体格检查发现左眼无光感、眼眶突出、眼睑无法闭合、眼球移位固定于颞上方，结膜高度充血水肿。影像学示左侧眼眶内见一较大类椭圆形混杂密度影，边界尚清。入院后予左眼眶占位完整切除，病理提示WDLS。

关键词:

眼眶, 高分化, 脂肪肉瘤, 临床病理

Liu Susu, Wang Nana, Chang Wenli, Si Hang, Shi Wenya, Zhang Qian.

A case of primary liposarcoma of orbit and clinicopathological analysis [J]. International Medicine and Health Guidance News, 2024, 30(10): 1720-1725.

刘素素王娜娜常文丽司航石文雅张骞.

眼眶原发性脂肪肉瘤1例及临床病理分析 [J]. 国际医药卫生导报, 2024, 30(10): 1720-1725.

References

[1] Gerry D, Fox NF, Spruill LS, et al. Liposarcoma of the head and neck: analysis of 318 cases with comparison to non-head and neck sites[J]. Head Neck, 2014, 36(3):393-400. DOI: 10.1002/hed.23311.
[2] Cai YC, McMenamin ME, Rose G, et al. Primary liposarcoma of the orbit: a clinicopathologic study of seven cases[J]. Ann Diagn Pathol, 2001, 5(5):255-266. DOI: 10.1053/adpa.2001.27911.
[3] Dermawan JK, Hwang S, Wexler L, et al. Myxoid pleomorphic liposarcoma is distinguished from other liposarcomas by widespread loss of heterozygosity and significantly worse overall survival: a genomic and clinicopathologic study[J]. Mod Pathol, 2022, 35(11):1644-1655. DOI: 10.1038/s41379-022-01107-6.
[4] Kransdorf MJ. Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location[J]. AJR Am J Roentgenol, 1995, 164(1):129-134. DOI: 10.2214/ajr.164.1.7998525.
[5] Andrea T, Giulio G, Giuliana L, et al. Primary dedifferentiated liposarcoma of the orbit, a rare entity: case report and review of literature[J]. Saudi J Ophthalmol, 2019, 33(3):312-315. DOI: 10.1016/j.sjopt.2019.01.003.
[6] Anderson WJ, Doyle LA. Updates from the 2020 World Health Organization classification of soft tissue and bone tumours[J]. Histopathology, 2021, 78(5):644-657. DOI: 10.1111/his.14265.
[7] Jakobiec FA, Rini F, Char D, et al. Primary liposarcoma of the orbit. Problems in the diagnosis and management of five cases[J]. Ophthalmology, 1989, 96(2):180-191. DOI: 10.1016/s0161-6420(89)32916-2.
[8] Lucas DR, Nascimento AG, Sanjay BK, et al. Well-differentiated liposarcoma. The Mayo Clinic experience with 58 cases[J]. Am J Clin Pathol, 1994, 102(5):677-683. DOI: 10.1093/ajcp/102.5.677.
[9] Guo S, Yang B, He X, et al. Clinical and pathological features of primary orbital liposarcoma in Chinese patients[J]. Curr Eye Res, 2023, 48(11):1078-1084. DOI: 10.1080/02713683.2023.2233117.
[10] Thway K. Well-differentiated liposarcoma and dedifferentiated liposarcoma: an updated review[J]. Semin Diagn Pathol, 2019, 36(2):112-121. DOI: 10.1053/j.semdp.2019.02.006.
[11] Mashima E, Sawada Y, Nakamura M. Recent advancement in atypical lipomatous tumor research[J]. Int J Mol Sci, 2021, 22(3):994. DOI: 10.3390/ijms22030994.
[12] Lee ATJ, Thway K, Huang PH, et al. Clinical and molecular spectrum of liposarcoma[J]. J Clin Oncol, 2018, 36(2):151-159. DOI: 10.1200/JCO.2017.74.9598.
[13] Forus A, Weghuis DO, Smeets D, et al. Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas[J]. Genes Chromosomes Cancer, 1995, 14(1):8-14. DOI: 10.1002/gcc.2870140103.
[14] Singer S, Socci ND, Ambrosini G, et al. Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma[J]. Cancer Res, 2007, 67(14):6626-6636. DOI: 10.1158/0008-5472.CAN-07-0584.
[15] Dei Tos AP, Doglioni C, Piccinin S, et al. Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours[J]. J Pathol, 2000, 190(5):531-536. DOI: 10.1002/(SICI)1096-9896(200004)190:5<531::AID-PATH579>3.0.CO;2-W.
[16] 李健.眼眶孤立性神经纤维瘤的影像学表现及病理对照分析[J].中国当代医药,2013,20(5):54-55.DOI:10.3969/j.issn.1674-4721.2013.05.027.
[17] Bijlsma WR, Elbert NJ, Kalmann R. The role of biopsy in diagnosing patients suspected of idiopathic orbital inflammation[J]. Curr Eye Res, 2012, 37(3):251-253. DOI: 10.3109/02713683.2011.639476.
[18] Park KS, Choi YJ, Song KS. Hyaline-vascular type Castleman's disease involving both orbits[J]. Acta Ophthalmol Scand, 2002, 80(5):537-539. DOI: 10.1034/j.1600-0420.2002.800514.x.
[19] Morimitsu Y, Nakajima M, Hisaoka M, et al. Extrapleural solitary fibrous tumor: clinicopathologic study of 17 cases and molecular analysis of the p53 pathway[J]. APMIS, 2000, 108(9):617-625. DOI: 10.1034/j.1600-0463.2000.d01-105.x.
[20] 孙海丽,游宇光.成人眼眶梭形细胞型横纹肌肉瘤1例[J].中国医学影像技术,2023,39(2):316.DOI:10.13929/j.issn.1003-3289.2023.02.042.
[21] 王秀军,陈维忠,卢立国,等.泪腺多形性腺瘤19例临床病理分析[J].医学信息(中旬刊),2011,24(2):461-462.DOI:10.3969/j.issn.1006-1959.2011.02.104.
[22] Cockerham KP, Kennerdell JS, Celin SE, et al. Liposarcoma of the orbit: a management challenge[J]. Ophthalmic Plast Reconstr Surg, 1998, 14(5):370-374. DOI: 10.1097/00002341-199809000-00013.
[23] Stiglmayer N, Jandrokovicć S, Miklicć P, et al. Atypical lipoma: well-differentiated liposarcoma of the orbit with dedifferentiated areas[J]. Orbit, 2003, 22(4):311-316. DOI: 10.1076/orbi.22.4.311.17247.
[24] Torrado CS, Zaldibar NM, Velasco-Benito V, et al. Primary orbital liposarcoma[J]. J Craniofac Surg, 2011, 22(3):1139-1141. DOI: 10.1097/SCS.0b013e3182108fdd.
[25] Borbolla-Pertierra AM, Morales-Baños DR, Martínez-Nava LR, et al. Orbital liposarcoma[J]. Arch Soc Esp Oftalmol, 2017, 92(2):86-92. DOI: 10.1016/j.oftal.2016.04.001.
[26] Lam TC, Yuen HKL, Cheuk W. Primary well-differentiated liposarcoma of the orbit[J]. Int J Surg Pathol, 2021, 29(4):406-407. DOI: 10.1177/1066896920925168.
[27] Gao N, Ge X, Pei C, et al. Orbital liposarcoma: a retrospective, single-center study of thirteen patients[J]. Int J Ophthalmol, 2023, 16(8):1293-1298. DOI: 10.18240/ijo.2023.08.16.
[28] Duffy MJ, Synnott NC, McGowan PM, et al. p53 as a target for the treatment of cancer[J]. Cancer Treat Rev, 2014, 40(10):1153-1160. DOI: 10.1016/j.ctrv.2014.10.004.
[29] Rayburn E, Zhang R, He J, et al. MDM2 and human malignancies: expression, clinical pathology, prognostic markers, and implications for chemotherapy[J]. Curr Cancer Drug Targets, 2005, 5(1):27-41. DOI: 10.2174/1568009053332636.
[30] de Jonge M, de Weger VA, Dickson MA, et al. A phase I study of SAR405838, a novel human double minute 2 (HDM2) antagonist, in patients with solid tumours[J]. Eur J Cancer, 2017, 76:144-151. DOI: 10.1016/j.ejca.2017. 02.005.
[31] Wagner AJ, Banerji U, Mahipal A, et al. Phase I trial of the human double minute 2 inhibitor MK-8242 in patients with advanced solid tumors[J]. J Clin Oncol, 2017, 35(12):1304-1311. DOI: 10.1200/JCO.2016.70.7117.
[32] Barretina J, Taylor BS, Banerji S, et al. Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy[J]. Nat Genet, 2010, 42(8):715-721. DOI: 10.1038/ng.619.
[33] Rosner M, Yosepovich A, Paul M, et al. Orbital well-differentiated liposarcoma demonstrating chromosomal imbalances[J]. Eye (Lond), 2006, 20(1):126-128. DOI: 10.1038/sj.eye.6701812.
[34] Madge SN, Tumuluri K, Strianese D, et al. Primary orbital liposarcoma[J]. Ophthalmology, 2010, 117(3):606-614. DOI: 10.1016/j.ophtha.2009.08.017.
[35] Jakobiec FA, Nguyen J, Bhat P, et al. MDM2-positive atypical lipomatous neoplasm/well-differentiated liposarcoma versus spindle cell lipoma of the orbit[J]. Ophthalmic Plast Reconstr Surg, 2010, 26(6):413-415. DOI: 10.1097/IOP.0b013e3181cd62eb.
[36] Al-Qahtani AA, Al-Hussain H, Chaudhry I, et al. Primary orbital liposarcoma: histopathologic report of two cases[J]. Middle East Afr J Ophthalmol, 2011, 18(4):314-316. DOI: 10.4103/0974-9233.90135.
[37] 李静,葛心,马建民.眼眶脂肪瘤局部复发恶变并文献复习[J/CD].中华眼科医学杂志(电子版),2012,2(2):30-31.
[38] Vrcek I, Hogan RN, Gilliland G. Orbital liposarcoma masquerading as a hemangioma[J]. Proc (Bayl Univ Med Cent), 2014, 27(4):359-360. DOI: 10.1080/08998280. 2014.11929159.
[39] Khurana S, Gupta AK, Sen S, et al. Primary liposarcoma of the orbit[J]. Indian J Pathol Microbiol, 2014, 57(4):617-619. DOI: 10.4103/0377-4929.142700.
[40] Dworak DP, Patel SA, Chennuri R, et al. Primary atypical lipomatous tumor of the orbit: a case report[J]. J Ophthalmic Vis Res, 2018, 13(1):78-80. DOI: 10.4103/jovr.jovr_208_15.
[41] McKey K, Zhang PJL, Shields CL, et al. Orbital atypical lipomatous tumor/well-differentiated liposarcoma masquerading as pleomorphic lipoma: a diagnostic challenge[J]. Ophthalmic Plast Reconstr Surg, 2019, 35(3):e76-e80. DOI: 10.1097/IOP.0000000000001378.
[42] Peck T, Gervasio KA, Zhang PJL, et al. Atypical lipomatous tumor/well-differentiated liposarcoma with myxoid stroma in a hereditary retinoblastoma survivor[J]. Ocul Oncol Pathol, 2020, 6(2):79-86. DOI: 10.1159/000501523.
[43] Kang JY, Kim HJ, Wojno TH, et al. Atypical lipomatous tumor/well-differentiated liposarcoma of the orbit: three cases and review of the literature[J]. Ophthalmic Plast Reconstr Surg, 2021, 37(3S):S134-S140. DOI: 10.1097/IOP.0000000000001804.
[44] Mei F, He L, Forouzan P, et al. Recurrent primary orbital well-differentiated liposarcoma /atypical lipomatous tumor: a rare case report with six-year follow-up[J]. Am J Ophthalmol Case Rep, 2022, 27:101602. DOI: 10.1016/j.ajoc.2022.101602.
[45] Mridha AR, Sharma MC, Sarkar C, et al. Primary liposarcoma of the orbit: a report of two cases[J]. Can J Ophthalmol, 2007, 42(3):481-483.

A case of primary liposarcoma of orbit and clinicopathological analysis

眼眶原发性脂肪肉瘤1例及临床病理分析

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 0

Recommended Articles

Metrics